Sorry, this section is only available in Japanese.
著者 (35件)：
資料名：
巻： 62 号： 7 ページ： 3336-3353 発行年： 2019年
JST資料番号： D0102A ISSN： 0022-2623 CODEN： JMCMAR 資料種別： 逐次刊行物 (A)
記事区分： 原著論文 発行国： アメリカ合衆国 (USA) 言語： 英語 (EN)
前のページに戻る
この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID：201902258332875596
整理番号：19A2352492
ピペラジニルアゼチジン骨格における”尾部スイッチング”戦略を用いた可逆的および不可逆的モノアシルグリセロールリパーゼ陽電子放出断層撮影(PET)トレーサの設計,合成および評価【JST・京大機械翻訳】
Design, Synthesis, and Evaluation of Reversible and Irreversible Monoacylglycerol Lipase Positron Emission Tomography (PET) Tracers Using a “Tail Switching” Strategy on a Piperazinyl Azetidine Skeleton
Chen Zhen
(Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Massachusetts, United States)
,
Chen Zhen
(Department of Chemistry, School of Science, Tianjin University, China)
,
Mori Wakana
(Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Japan)
,
Deng Xiaoyun
(Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Massachusetts, United States)
,
Cheng Ran
(Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Massachusetts, United States)
,
Ogasawara Daisuke
(The Skaggs Institute for Chemical Biology and Department of Chemical Physiology, The Scripps Research Institute, California, United States)
,
Zhang Genwei
(Department of Chemistry and Biochemistry, University of Oklahoma, Oklahoma, United States)
,
Schafroth Michael A.
(The Skaggs Institute for Chemical Biology and Department of Chemical Physiology, The Scripps Research Institute, California, United States)
,
Dahl Kenneth
(Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Massachusetts, United States)
,
Fu Hualong
(Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Massachusetts, United States)
,
Hatori Akiko
(Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Japan)
,
Shao Tuo
(Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Massachusetts, United States)
,
Zhang Yiding
(Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Japan)
,
Yamasaki Tomoteru
(Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Japan)
,
Zhang Xiaofei
(Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Massachusetts, United States)
,
Rong Jian
(Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Massachusetts, United States)
,
Yu Qingzhen
(Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Massachusetts, United States)
,
Hu Kuan
(Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Japan)
,
Fujinaga Masayuki
(Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Japan)
,
Xie Lin
(Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Japan)
,
Kumata Katsushi
(Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Japan)
,
Gou Yuancheng
(ChemShuttle, Inc., Jiangsu, China)
,
Chen Jingjin
(ChemShuttle, Inc., Jiangsu, China)
,
Gu Shuyin
(ChemShuttle, Inc., Jiangsu, China)
,
Bao Liang
(ChemShuttle, Inc., Jiangsu, China)
,
Wang Lu
(Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Massachusetts, United States)
,
Collier Thomas Lee
(Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Massachusetts, United States)
,
Vasdev Neil
(Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Massachusetts, United States)
,
Shao Yihan
(Department of Chemistry and Biochemistry, University of Oklahoma, Oklahoma, United States)
,
Ma Jun-An
(Department of Chemistry, School of Science, Tianjin University, China)
,
Cravatt Benjamin F.
(The Skaggs Institute for Chemical Biology and Department of Chemical Physiology, The Scripps Research Institute, California, United States)
,
Fowler Christopher
(Department of Pharmacology and Clinical Neuroscience, Umea University, Sweden)
,
Josephson Lee
(Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Massachusetts, United States)
,
Zhang Ming-Rong
(Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Japan)
,
Liang Steven H.
(Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Massachusetts, United States)
資料名：
Journal of Medicinal Chemistry
(Journal of Medicinal Chemistry)
巻： 62 号： 7 ページ： 3336-3353 発行年： 2019年
JST資料番号： D0102A ISSN： 0022-2623 CODEN： JMCMAR 資料種別： 逐次刊行物 (A)
記事区分： 原著論文 発行国： アメリカ合衆国 (USA) 言語： 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。